Evaluation of starch from new sweet potato genotypes for use as a pharmaceutical diluent, binder or disintegrant

24Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

Starches from four new sweet potato genotypes were evaluate for use as tablet diluents, binders and disintegrants; using a commercially available maize starch as reference. The pre-formulation studies established low pH (5.1-5.9) and moisture content (10.0-13.1%), but high bulk density (0.50-0.58), tapped density (0.75-0.82) and true density (1.15-1.18) for the sweet potato starches. Hardness and friability of tablets formulated with sweet potato starches as binder were significantly better (p = 0.001) than similar compacts containing maize starch. The sweet potato starches also caused significantly faster tablet disintegration and release of paracetamol (p = 0.005). The results established the sweet potato starches as stronger pharmaceutical diluents, binders and disintegrants, compared to the commercially available maize starch. © 2013 Manoharan Sharanya et al.

Cite

CITATION STYLE

APA

Bayor, M. T., Tuffour, E., & Lambon, P. S. (2013). Evaluation of starch from new sweet potato genotypes for use as a pharmaceutical diluent, binder or disintegrant. Journal of Applied Pharmaceutical Science, 3(8 SUPPL). https://doi.org/10.7324/JAPS.2013.38.S4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free